Formulation challenges are often associated with protein delivery vehicles, and controlled-release strategies that deliver medications locally are believed to offer some advantages. Most biologic
formulations are made for a parenteral route of administration, but novel approaches, such as the use of microcellular foams, are being developed to enhance administration profiles and patient
compliance.
